Most Commented
-
34 comments
-
21 comments
-
17 comments
-
11 comments
-
10 comments
Thanks to our major sponsors
MinnPost Staff
- CEO/Editor: Joel Kramer
- Chief Revenue Officer: Laurie Kramer
- Co-Managing Editor: Roger Buoen
- Co-Managing Editor: Susan Albright
- Web Editor: Corey Anderson
- News Editor: Don Effenberger
- Director of News Technology: Kaeti Hinck
- Advertising Director: Sally Waterman
- Web Producer: Tom Nehil
- Interactive News Developer: Alan Palazzolo
- Advertising Operations Director: Brian Perry
- Advertising Account Executive: Matthew Becker
- Membership Coordinator: Ashleigh Swenson
- Office Manager: Sandy Lewis
- Business Manager: Bryan Powell
- Board Chair: Lee Lynch
MinnPost is a nonprofit, nonpartisan enterprise whose mission is to provide high-quality journalism for news-intense people who care about Minnesota.
Thanks to our generous donors
- Blandin Foundation
- Otto Bremer Foundation
- Bush Foundation
- Central Corridor Funders Collaborative
- Bill & Sharon Clapp
- Sage & John Cowles
- Jay & Page Cowles
- David & Vicki Cox
- Toby & Mae Dayton
- Jack & Claire Dempsey
- Ethics and Excellence in Journalism Foundation
- Jill & Larry Field
- Great River Energy
- Sam Heins & Stacey Mills
- John S. and James L. Knight Foundation
- Joel & Laurie Kramer
- The Joyce Foundation
- Lee Lynch & Terry Saario
- Martin and Brown Foundation
- The McKnight Foundation
- The Minneapolis Foundation
- Northwest Area Foundation
- Jeremy Edes Pierotti & Kathryn Klibanoff
- Pohlad Family Foundation
- The Saint Paul Foundation
- John & Linda Satorius
- Rebecca & Mark Shavlik
Donations and pledges totaling $25,000 or more have been made by each of the families and foundations listed. For a list of all donors by category, see our most recent Year End Report.
If public money is paying for the research, why doesn't the public enjoy a portion of the profits as well? The public needs a return on their money! I'd like to see that money go into supporting medicare and medicaid, for starters. Or if Big Pharma is unwilling to share, revise the tax code for Big Pharma.